Areas for Improvement in Real-World GPRC5D-Targeted Therapy Application

Opinion
Video

Panelists discuss how key areas for improvement in the application of GPRC5D-targeted therapies in real-world settings include optimizing patient selection, addressing logistical challenges, and enhancing adverse event management.

Recent Videos
4 KOLs are featured in this series.
4 KOLs are featured in this series.
4 KOLs are featured in this series.
9 Experts are featured in this series.
9 Experts are featured in this series.
2 experts are featured in this series.
Vinay K. Puduvalli, MD, is featured in this series.
9 Experts are featured in this series.
9 Experts are featured in this series.
Patients treated with BCMA-directed immunotherapies for myeloma may experience susceptibility to severe infections following treatment.
Related Content